Ignite Creation Date:
2025-12-25 @ 12:38 AM
Ignite Modification Date:
2025-12-28 @ 2:06 PM
Study NCT ID:
NCT01096667
Status:
COMPLETED
Last Update Posted:
2018-09-13
First Post:
2010-03-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Safety and Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes And Hypertension (MK-8835-042)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-05-17
Start Date Type:
ACTUAL
Primary Completion Date:
2011-02-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-02-25
Completion Date Type:
ACTUAL
First Submit Date:
2010-03-26
First Submit QC Date:
None
Study First Post Date:
2010-03-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-11-15
Results First Submit QC Date:
None
Results First Post Date:
2017-12-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2013-04-16
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2018-08-15
Last Update Post Date:
2018-09-13
Last Update Post Date Type:
ACTUAL